VYNE - Rega marang dodolan VYNE Therapeutics Inc

Tandha merek vynetherapeutics.com (VYNE)

VYNE Therapeutics (VYNE) business protection relies on the patent purity of foam compositions and pharmacy distribution. This P/S chart visualizes the market valuation of these advantages, where the 54.40 mark characterizes this parameter. Stable demand for dermatology guarantees macro-stability regardless of the economy, while successful mid-stage trials and preparation for the final R&D phase create powerful growth catalysts.

VYNE (VYNE Therapeutics) riwayat Multiplikator P/S saka 04.07.2022 nganti 28.07.2026

VYNE Therapeutics (VYNE) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Analisis umum perusahaan:VYNE Therapeutics Inc, VYNE
Produk dadi VYNE Therapeutics Inc

A stable team of leading biochemical dermatologists provides VYNE Therapeutics (VYNE) with high fundamental reliability and protection of its intellectual capital. The P/S ratio, reflecting the relationship between market capitalization and annual revenue, allows for the valuation of the business relative to its sales; by analyzing the P/S ratio chart, an investor can determine the degree of overpayment for the asset, confirming the company's stability by comparing the market price with actual revenue.